Cargando…

Epithelial–Mesenchymal Transition-Based Gene Signature and Distinct Molecular Subtypes for Predicting Clinical Outcomes in Breast Cancer

PURPOSE: Regulation of inducers and transcription factor families influence epithelial–mesenchymal transition (EMT), a contributing factor to breast cancer invasion and progression. METHODS: Molecular subtypes were classified based on EMT-related mRNAs using ConsensusClusterPlus package. Differences...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Lili, Hou, Shuang, Yin, Lei, Zhao, Shuai, Li, Xiaohua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979091/ https://www.ncbi.nlm.nih.gov/pubmed/35386860 http://dx.doi.org/10.2147/IJGM.S343885

Ejemplares similares

Epithelial to Mesenchymal Transition Relevant Subtypes with Distinct Prognosis and Responses to Chemo- or Immunotherapies in Osteosarcoma
por: Zhou, Yang, et al.
Publicado: (2022)

Exploration of epithelial-mesenchymal transition-related lncRNA signature and drug sensitivity in breast cancer
por: Li, Chengxin, et al.
Publicado: (2023)

Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front
por: De Wever, Olivier, et al.
Publicado: (2008)

A novel epithelial‐mesenchymal transition molecular signature predicts the oncological outcomes in colorectal cancer
por: Shan, Zezhi, et al.
Publicado: (2021)

Proteomic characterization of epithelial ovarian cancer delineates molecular signatures and therapeutic targets in distinct histological subtypes
por: Gong, Ting-Ting, et al.
Publicado: (2023)

Epithelial–Mesenchymal Transition Expression Profile Stratifies Human Glioma into Two Distinct Tumor-Immune Subtypes
por: Ren, Changyuan, et al.
Publicado: (2023)

The Molecular Mechanism of Epithelial–Mesenchymal Transition for Breast Carcinogenesis
por: Li, Chia-Jung, et al.
Publicado: (2019)

TP53 Mutation, Epithelial-Mesenchymal Transition, and Stemlike Features in Breast Cancer Subtypes
por: Coradini, Danila, et al.
Publicado: (2012)

Distinct outcomes in patients with different molecular subtypes of inflammatory breast cancer
por: Zhou, Jingyu, et al.
Publicado: (2014)

Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Chemotherapy in Acute Myeloid Leukemia
por: Qu, Shuang, et al.
Publicado: (2023)

In primary airway epithelial cells, the unjamming transition is distinct from the epithelial-to-mesenchymal transition
por: Mitchel, Jennifer A., et al.
Publicado: (2020)

Development and validation of an epithelial–mesenchymal transition-related gene signature for predicting prognosis
por: Zhou, De-Hua, et al.
Publicado: (2022)

Immunohistochemical-based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial-mesenchymal transition
por: Banias, Laura, et al.
Publicado: (2020)

A Six-Epithelial–Mesenchymal Transition Gene Signature May Predict Metastasis of Triple-Negative Breast Cancer
por: Wei, Li Yuan, et al.
Publicado: (2020)

CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression
por: Liang, Qian, et al.
Publicado: (2013)

Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability
por: Hong, Shubin, et al.
Publicado: (2022)

Molecular Signatures of the Insulin-Like Growth Factor 1-Mediated Epithelial-Mesenchymal Transition in Breast, Lung and Gastric Cancers
por: Cevenini, Armando, et al.
Publicado: (2018)

Epithelial to mesenchymal transition and breast cancer
por: Tomaskovic-Crook, Eva, et al.
Publicado: (2009)

Epithelial-Mesenchymal Transition and Breast Cancer
por: Wu, Yanyuan, et al.
Publicado: (2016)

ERRATUM: CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression
por: Liang, Qian, et al.
Publicado: (2014)

An individualized transcriptional signature to predict the epithelial-mesenchymal transition based on relative expression ordering
por: Chen, Tingting, et al.
Publicado: (2020)

Integrating bulk and single-cell RNA sequencing data reveals epithelial-mesenchymal transition molecular subtype and signature to predict prognosis, immunotherapy efficacy, and drug candidates in low-grade gliomas
por: Wang, Chengcheng, et al.
Publicado: (2023)

Assessment of epithelial–mesenchymal transition signatures in oral submucous fibrosis
por: Prasad, R Shesha, et al.
Publicado: (2019)

Cancer-Associated Stemness and Epithelial-to-Mesenchymal Transition Signatures Related to Breast Invasive Carcinoma Prognostic
por: Groza, Iulia-Monica, et al.
Publicado: (2020)

Distinct molecular subtypes of systemic sclerosis and gene signature with diagnostic capability
por: Wang, Qi, et al.
Publicado: (2023)

Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition
por: Roepman, Paul, et al.
Publicado: (2014)

TFDP3 Regulates Epithelial-Mesenchymal Transition in Breast Cancer
por: Yin, Kailin, et al.
Publicado: (2017)

Investigating the Link between Molecular Subtypes of Glioblastoma, Epithelial-Mesenchymal Transition, and CD133 Cell Surface Protein
por: Zarkoob, Hadi, et al.
Publicado: (2013)

Effects of miR-93 on epithelial-to-mesenchymal transition and vasculogenic mimicry in triple-negative breast cancer cells
por: An, Gaili, et al.
Publicado: (2021)

An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients
por: Zhu, Gongmin, et al.
Publicado: (2021)

Identification of a Novel Epithelial–Mesenchymal Transition Gene Signature Predicting Survival in Patients With HNSCC
por: Xin, Wei, et al.
Publicado: (2021)

Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer
por: Song, Junquan, et al.
Publicado: (2022)

Prognostic significance of expression of epithelial-mesenchymal transition driver brachyury in breast cancer and its association with subtype and characteristics
por: Lee, Kwan Ho, et al.
Publicado: (2018)

Mesenchymal-to-epithelial transitions require tissue-specific interactions with distinct laminins
por: Pitsidianaki, Ioanna, et al.
Publicado: (2021)

Molecular genetic characteristics of thymic epithelial tumors with distinct histological subtypes
por: Yang, Jun, et al.
Publicado: (2023)

Superior breast cancer metastasis risk stratification using an epithelial-mesenchymal-amoeboid transition gene signature
por: Emad, Amin, et al.
Publicado: (2020)

Expression of the prognostic marker IL‐8 correlates with the immune signature and epithelial‐mesenchymal transition in breast cancer
por: Liao, Huifeng, et al.
Publicado: (2023)

Epithelial–Mesenchymal Transition Gene Signature Related to Prognostic in Colon Adenocarcinoma
por: Busuioc, Constantin, et al.
Publicado: (2021)

Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review
por: Wang, Shuai, et al.
Publicado: (2017)

Identification of Epithelial–Mesenchymal Transition-Related lncRNA With Prognosis and Molecular Subtypes in Clear Cell Renal Cell Carcinoma
por: Zhong, Weimin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jv79d7tr7qsghhigfb3d6pvgri